Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 11/20 | 0.47 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | CETP | P11597 | 3/20 | 0.43 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9716343 | 0.89 | PLA2G10 (0.48) | TLR2PLA2G10PLA2G2ACETPPLA2G4B | |
| SCHEMBL10598022 | 0.88 | CES2 (0.48) | TLR2PLA2G10PLA2G2ACETPPLA2G4B | |
| SCHEMBL9716325 | 0.85 | TLR2 (0.48) | TLR2CETP | |
| SCHEMBL25078765 | 0.83 | PLA2G10 (0.55) | TLR2PLA2G10PLA2G2ACETP | |
| SCHEMBL4368865 | 0.83 | PLA2G10 (0.55) | TLR2PLA2G10PLA2G2ACETP | |
| SCHEMBL2411902 | 0.83 | PLA2G10 (0.55) | TLR2PLA2G10PLA2G2ACETP | |
| SCHEMBL25078776 | 0.83 | PLA2G10 (0.55) | TLR2PLA2G10PLA2G2ACETP | |
| SCHEMBL6813695 | 0.83 | PLA2G10 (0.50) | TLR2PLA2G10PLA2G2ACETP | |
| SCHEMBL2411920 | 0.83 | PLA2G10 (0.55) | TLR2PLA2G10PLA2G2ACETP | |
| SCHEMBL13997509 | 0.83 | PLA2G10 (0.55) | TLR2PLA2G10PLA2G2ACETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5103007-A | Antitumor agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-04-07 | — | — | US | disclosed |
| EP-0378763-A1 | Lipids, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1990-07-25 | — | — | EP | disclosed |